These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9255578)

  • 1. Alterations in the K-ras and p53 genes in rat lung tumors.
    Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
    Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
    Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors.
    Nickell-Brady C; Hahn FF; Finch GL; Belinsky SA
    Carcinogenesis; 1994 Feb; 15(2):257-62. PubMed ID: 7545909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
    Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
    Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.
    Oreffo VI; Lin HW; Padmanabhan R; Witschi H
    Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, erbB-2 and K-ras gene alterations are rare in spontaneous and plutonium-239-induced canine lung neoplasia.
    Tierney LA; Hahn FF; Lechner JF
    Radiat Res; 1996 Feb; 145(2):181-7. PubMed ID: 8606928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane.
    Stowers SJ; Glover PL; Reynolds SH; Boone LR; Maronpot RR; Anderson MW
    Cancer Res; 1987 Jun; 47(12):3212-9. PubMed ID: 3581065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
    Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
    Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
    Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
    Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
    Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
    Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
    Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microdissection and PCR-SSCP detected mutation and expression of p53 and K-ras gene in carcinogenesis and development of induced rat lung carcinoma].
    Li H; Liu M; Diao L; Yu L; Chen H; Chen F; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):331-6. PubMed ID: 12417091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene.
    Shafarenko M; Mahler J; Cochran C; Kisielewski A; Golding E; Wiseman R; Goodrow T
    Carcinogenesis; 1997 Jul; 18(7):1423-6. PubMed ID: 9230291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
    Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
    Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.